To address multidrug resistance (MDR) in breast cancer, a multifunctional liposome (RID-LPs) was developed by replacing cholesterol with ginsenoside Rg3 and incorporating DSPE-PEG2000 for prolonged systemic circulation. This nanoplatform encapsulates...
Xie et al. (Thu,) studied this question.